Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
Link opens in a new tab
University of Texas Southwestern Medical Center Home
Search content at University of Texas Southwestern Medical Center
Home
Profiles
Research units
Equipment
Research output
Comorbidity and Disease Activity in Multiple Sclerosis
Amber Salter
, Samantha Lancia
, Kaarina Kowalec
, Kathryn C. Fitzgerald
, Ruth Ann Marrie
Neurology & Neurotherapeutics
Neurology & Neurotherapeutics - NE Multiple Sclerosis Section
Cntr For Brain Injury & Repair
UTSW ODL Brain Inst
Research output
:
Contribution to journal
›
Article
›
peer-review
39
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Comorbidity and Disease Activity in Multiple Sclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
2-stage
9%
2-year Follow-up
9%
Accruals
9%
Adjusted Hazard Ratio
27%
Autoimmune Disease
9%
Autoimmune Thyroid Disease
9%
Cardiac Magnetic Resonance Imaging (cMRI)
18%
Cardiometabolic Comorbidities
9%
Cardiometabolic Disease
9%
Cardiovascular Disease
9%
Clinical Outcomes
9%
Clinical Practice
9%
Clinical Trialists
9%
Clinical Trials
18%
Clinically Meaningful Outcomes
9%
Comorbidity
100%
Comorbidity Burden
9%
Diabetes
9%
Disability Severity
9%
Disability Worsening
18%
Disease Activity
100%
Disease-modifying Therapy
9%
High Burden
9%
Hypertension
9%
Individual Participant Data
9%
Ischemic Heart
9%
Lung Condition
9%
Meta-analytic Approach
9%
Migraine
9%
Multiple Sclerosis
100%
Multiple Sclerosis Disease-modifying Therapies
9%
Multiple Sclerosis Treatment
9%
Negative Prognostic Factors
9%
New Lesions
9%
Other Psychiatric Disorders
9%
Partial Mediator
9%
Peripheral Vascular Disease
9%
Phase I Trial
9%
Relapse Pattern
9%
Relapse Rate
9%
Skin Condition
9%
Trial Enrollment
9%
Working Diagnosis
9%
Medicine and Dentistry
Autoimmunity
15%
Cardiovascular Disease
7%
Clinical Trial
23%
Clinician
7%
Cohort Analysis
7%
Comorbidity
100%
Diabetes
7%
Disability Severity
7%
Disease Activity
100%
Disease Modifying Therapy
15%
Hazard Ratio
23%
Hyperlipidemia
7%
Hypertension
7%
Ischemic Heart Disease
7%
Lung
7%
Magnetic Resonance Imaging
15%
Mediator
7%
Migraine
7%
Multiple Sclerosis
100%
Neurodevelopmental Disorder
15%
Peripheral Vascular Disease
7%
Prognostic Factor
7%
Recurrence Risk
7%
Thyroid Gland
7%
Nursing and Health Professions
Cardiovascular Disease
7%
Clinical Outcome
7%
Clinical Practice
7%
Clinical Trial
23%
Cohort Analysis
7%
Comorbidity
100%
Disability Severity
7%
Disease Activity
100%
Diseases
15%
Hazard Ratio
23%
Heart Muscle Ischemia
7%
Hyperlipidemia
7%
Hypertension
7%
Mental Diseases
7%
Migraine
7%
Multiple Sclerosis
100%
Nuclear Magnetic Resonance Imaging
15%
Peripheral Vascular Disease
7%
Recurrence Risk
7%